GPN Vaccines has raised $10.0M as the clinical-stage company works on vaccines against some of the world's most important bacterial pathogens. The Australian firm is developing products designed to provide robust protection against these threats.

Get the full GPN Vaccines company profile
Access contacts, investors, buying signals & more
GPN Vaccines has raised $10.0M as the clinical-stage company works on vaccines against some of the world's most important bacterial pathogens. The Australian firm is developing products designed to provide robust protection against these threats.
GPN Vaccines Raises $10 Million To Advance Gamma-PN Pneumococcal Vaccine Toward Phase 2 Trials GPN Vaccines Raises $10 Million To Advance Gamma-PN Pneumococcal Vaccine Toward Phase 2 Trials GPN Vaccines, a clinical-stage biotechnology company developing broadly protective bacterial vaccines, has closed a fully subscribed $10 million private placement with participation from new and existing investors.
The financing will support preparations to advance its lead investigational vaccine, Gamma-PN, into Phase 2 clinical development. The proceeds will fund several development activities, including current Good Manufacturing Practice (cGMP) batch manufacturing, expansion of the company鈥檚 opsonophagocytic activity (OPA) testing laboratory, and preparation of an Investigational New Drug application for

SuperIT
We are building AI agents that supercharge IT teams, with a focus on AI that solves real IT issues for end users. Our mission is to redefine how IT services are delivered for businesses: faster response, deeper insight, and 10x the scalability - without 10x the headcount.
$1.7M Pre-seed
today

Lightning Minerals
Lightning Minerals (ASX:L1M) is currently focused on exploring copper and gold assets in Queensland and NSW, Australia.
$509.9K Unknown
4 days ago

Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 | ![]() NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Unknown round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Stemora, Inc. | Unknown | $25.0K | today |
| 2 | ![]() Tenet Diagnostics India | Unknown | $30.0M | today |
MP Space
Building the hardware driving the space industrial era. Built to perform. Easy to integrate. Ready to fly.
$11.3M Seed
8 days ago
| $7.2B |
| 2y ago |
| 3 | ![]() GRAIL United States | Unknown | $7.1B | 2y ago |
| 4 | ![]() Illumina United States | Unknown | $7.1B | 2y ago |
| 5 | ![]() RemeGen Biosciences United States | Grant | $5.6B | 9mo ago |
| 3 |
![]() flipflow Spain |
| Unknown |
| $3.4M |
| today |
| 4 | ![]() Archiboost AI United States | Unknown | $6.2M | today |
| 5 | ![]() Biotts Poland | Unknown | $6.3M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in GPN Vaccines and reach their contacts directly.
Start free trial
Stemora, Inc.
Recently received

Thryv Therapeutics Inc.
Recently received

BionicM
Recently received